Get all your news in one place.
100's of premium titles.
One app.
Start reading
ABC News
ABC News
Health
science reporter Belinda Smith

COVID-19 vaccine from Moderna 'provides good clinical protection' against Omicron subvariants

COVID vaccines currently approved for use around the world are based on the ancestral SARS-CoV-2 virus. (Getty Images: Andriy Onufriyenko)

Moderna's experimental Omicron booster generates high levels of antibodies that neutralise subvariants BA.4 and BA.5, according to preliminary clinical trial data.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.